Opinion|Videos|January 8, 2025
Tailoring Treatment Approaches for Fit vs Unfit CLL Patients
A panel of medical experts continues their discussion surrounding an array of treatment options for CLL.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How does your treatment approach differ for IGHV-mutated vs unmutated CLL?
Advertisement
Related to this article
The top 5 OncLive TV videos of the week cover pancreatic cancer, gastric cancer, GIST, renal cell carcinoma, and chronic lymphocytic leukemia.
Advertisement
Advertisement
Trending on OncLive
1
Five Under 5: Top Oncology Videos for the Week of 8/31/26
2
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
3
B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer
4
The OncFive: Top Oncology Articles for the Week of 8/30
5